ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Corticosterone is as effective as cortisol for ACTH suppression but lacks metabolic adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Differential tissue expression of the glucocorticoid transmembrane transporters has led to the consideration of corticosterone as an alternative therapeutic option in treating CAH, with potentially decreased effects on peripheral tissues and enhanced influence on the HPA axis117.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation
Wabitsch, M., Brenner, R., Melzner, I., Braun, M., Möller, P., Heinze, E., Debatin, K.-M., & Hauner, H. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801520 · Cited by 562
Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., Valk, M. V. D., Krimpenfort, P., & Borst, P. (1997) · Nature Medicine · doi:10.1038/nm1197-1275 · Cited by 432
Gekeler, V., Ise, W., Sanders, K. H., Ulrich, W. R., & Beck, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1344 · Cited by 396
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385
Self-citationUltradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription
Stavreva, D. A., Wiench, M., John, S., Conway-Campbell, B. L., McKenna, M. A., Pooley, J. R., Johnson, T. A., Voss, T. C., Lightman, S. L., & Hager, G. L. (2009) · Nature Cell Biology · doi:10.1038/ncb1922 · Cited by 375
Meijer, O. C. (1998) · Endocrinology · doi:10.1210/en.139.4.1789 · Cited by 375
Karssen, A. M. (2001) · Endocrinology · doi:10.1210/en.142.6.2686 · Cited by 280
Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans
Djurhuus, C. B., Gravholt, C. H., Nielsen, S., Mengel, A., Christiansen, J. S., Schmitz, O. E., & Møller, N. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00544.2001 · Cited by 219
Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay
Tiberghien, F., & Loor, F. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199607000-00012 · Cited by 187
Cortisol—cause and cure for metabolic syndrome?
Walker, B. R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01998.x · Cited by 179 · cited 2×
“Current treatment guidelines recommend cortisol (hydrocortisone) as the treatment of choice, but recent studies have found that the doses required to suppress adrenal androgen production are usually associated with adverse effects (1, 2), notably in adipose tissuewhere chronic glucocorticoid excess promotes obesity an…”
BackgroundSelf-citationMetabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
Dinneen, S., Alzaid, A., Miles, J., & Rizza, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116832 · Cited by 175
Studies of the control of plasma aldosterone concentration in normal man
Dluhy, R. G., Axelrod, L., Underwood, R. H., & Williams, G. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107001 · Cited by 165
Reddy, T. E., Gertz, J., Crawford, G. E., Garabedian, M. J., & Myers, R. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-12 · Cited by 149 · cited 2×
“Of these, only PER1was induced acutely (2 hours) by glucocorticoids, consistent with its rapid response (18) and high sensitivity (19) in other systems.”
BackgroundMcInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T. K., Andrew, R., & Walker, B. R. (2012) · Diabetes · doi:10.2337/db11-1136 · Cited by 132 · cited 2×
“Differentiation was induced as previously described (37).”
MethodSelf-citationWEST, C. D., MAHAJAN, D. K., CHAVRÉ, V. J., NABORS, C. J., & TYLER, F. H. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-6-1230 · Cited by 116
Treatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102
Self-citationAndrew, R., Smith, K., Jones, G. C., & Walker, B. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8157 · Cited by 98
Self-citationThe role of corticosterone in human hypothalamic– pituitary–adrenal axis feedback
Raubenheimer, P. J., Young, E. A., Andrew, R., & Seckl, J. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02540.x · Cited by 94
Self-citationOddie, C. J., Coghlan, J. P., & Scoggins, B. A. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-6-1039 · Cited by 93
Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy
Baudoux, T. E. R., Pozdzik, A. A., Arlt, V. M., Prez, E. D., Antoine, M.-H., Quellard, N., Goujon, J., & Nortier, J. (2012) · Kidney International · doi:10.1038/ki.2012.264 · Cited by 86
Primary Culture and Differentiation of Human Adipocyte Precursor Cells
van Harmelen, V., Skurk, T., & Hauner, H. (2004) · Human Cell Culture Protocols · doi:10.1385/1-59259-861-7:125 · Cited by 82
Interaction of glucocorticoid analogues with the human glucocorticoid receptor
Berger, T. S., Parandoosh, Z., Perry, B. W., & Stein, R. B. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90414-e · Cited by 76 · cited 1×
“Although results of human glucocorticoid receptor (GR) binding studies are inconsistent (4, 5), both glucocorticoids appear to have similar affinities for mineralocorticoid receptors (6) and are subject to similar metabolism (7).”
BackgroundThe Simultaneous Assay of Cortisol, Corticosterone, 11-Deoxycortisol, and Cortisone in Human Plasma1
Newsome, H. H., CLEMENTS, A. S., & Borum, E. H. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-3-473 · Cited by 72
ADRENOCORTICOSTEROIDS IN PERIPHERAL AND ADRENAL VENOUS BLOOD OF MAN*†
Sweat, M. L., & Lipscomb, M. D. (1955) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-15-9-1043 · Cited by 72
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Stimson, R. H., Rees, D. A., Krone, N., Willis, D. S., Conway, G. S., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), U. K. C. A. H. A. S. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12045 · Cited by 70
Self-citationMason, B. L., Pariante, C. M., & Thomas, S. A. (2008) · Endocrinology · doi:10.1210/en.2008-0041 · Cited by 66
DOUBLE ISOTOPE ASSAY OF ALDOSTERONE, CORTICOSTERONE AND CORTISOL IN HUMAN PERIPHERAL PLASMA
Fraser, R., & James, V. H. T. (1968) · Journal of Endocrinology · doi:10.1677/joe.0.0400059 · Cited by 65
Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response
Webster, J. I., & Carlstedt‐Duke, J. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00227-3 · Cited by 60
PLASMA CORTICOSTERONE AND HYDROCORTISONE LEVELS IN MAN
Peterson, R. E. (1957) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-17-10-1150 · Cited by 55
5α-Reduced Glucocorticoids, Novel Endogenous Activators of the Glucocorticoid Receptor
McInnes, K. J., Kenyon, C. J., Chapman, K. E., Livingstone, D. E. W., Macdonald, L. J., Walker, B. R., & Andrew, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402822200 · Cited by 52
Self-citationAn inexpensive small volume equilibrium dialysis system for protein-ligand binding assays
Reinard, T., & Jacobsen, H. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90286-8 · Cited by 51
Wake, D. J., Stimson, R. H., Tan, G. D., Homer, N. Z. M., Andrew, R., Karpe, F., & Walker, B. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2713 · Cited by 43
Self-citationSpecies-Related Differences in Steroid-Binding Specificity of Glucocorticoid Receptors in Lung*
Γιαννόπουλος, Γ., & KEICHLINE, D. (1981) · Endocrinology · doi:10.1210/endo-108-4-1414 · Cited by 42
Glucocorticoids Turn Over Slowly in Human Adipose Tissue in Vivo
Hughes, K. A., Reynolds, R. M., Andrew, R., Critchley, H. O. D., & Walker, B. R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0384 · Cited by 32
Self-citationMultimodal, label‐free nonlinear optical imaging for applications in biology and biomedical science
Mouras, R., Bagnaninchi, P., Downes, A., & Elfick, A. P. D. (2013) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4305 · Cited by 31
Self-citationSTUDIES OF ADRENAL CORTICOSTEROIDS. I. ESTIMATION OF PLASMA CORTICOSTERONE AND CORTISOL*
Ely, R. S., Hughes, E. R., & Kelley, V. C. (1958) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-18-2-190 · Cited by 26
Hüther, K. J., & Scholz, H. (1969) · Hormone and Metabolic Research · doi:10.1055/s-0028-1096845 · Cited by 18
Nishida, S., Matsumura, S., Horino, M., Oyama, H., & Tenku, A. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-3-585 · Cited by 16
Hüther, K. J., & Hr, S. (1970) · Hormone and Metabolic Research · doi:10.1055/s-0028-1095054 · Cited by 14
Voice, M. W., Seckl, J. R., & Chapman, K. E. (1996) · Gene · doi:10.1016/s0378-1119(96)00490-8 · Cited by 10
Research works printed but not linked: 2
- 10.1210/endo.139.4.5917 · doi:10.1210/endo.139.4.5917 · Paper page
- 10.1210/endo.142.6.8213 · doi:10.1210/endo.142.6.8213 · Paper page
Cited by
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
The cortisol switch between vulnerability and resilience
de Kloet, E. R., & Joëls, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01934-8 · Cited by 174
“In rodents two Abcb1 isoforms – Abcb1a and Abcb1b-exist, the former being the one abundantly expressed in the blood-brain barrier [225, 226].”
Meakin, A. S., Cuffe, J. S. M., Darby, J. R. T., Morrison, J. L., & Clifton, V. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126386 · Cited by 158
“[64] reported increased mRNA expression of Abcb1a in female placentae in response to stress.”
BackgroundVARIDT 1.0: variability of drug transporter database
Yin, J., Sun, W. C., Li, F., Hong, J., Li, X., Zhou, Y., Lu, Y., Liu, M., Zhang, X. Z., Chen, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz779 · Cited by 141
“There are three aspects of variability: (a) epigenetic regulation and genetic polymorphism of DT that are key in drug resistance (5) and clinical treatment optimization (6); (b) species, tissue- and disease-specific DT abundances that are vital in bridging preclinical study with clinical trial (7), balancing efficacy…”
BackgroundManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Metadata
- Authors
- Nixon, M., Mackenzie, S. D., Taylor, A. I., Homer, N. Z. M., Livingstone, D. E., Mouras, R., Morgan, R. A., Mole, D. J., Stimson, R. H., Reynolds, R. M., Elfick, A. P. D., Andrew, R., & Walker, B. R.
- Affiliations
- British Heart Foundation Centre for Cardiovascular Science (GB)
- The Queen's Medical Research Institute (GB)
- University of Edinburgh (GB)
- Centre for Inflammation Research (GB)
- Corresponding author
- Nixon, Mark
- Mackenzie, Scott D.
- Taylor, Ashley I.
- Walker, Brian R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-08-17
- Volume
- 8
- Issue
- 352
- Pages
- 352ra109-352ra109
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2510336674
- Cited by
- 59
- References
- 44
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 6 · 2019: 9 · 2018: 4 · 2017: 4 · 2016: 1
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation
- Wellcome Trust
- Medical Research Council
- Engineering and Physical Sciences Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- MRP1, corticosterone, cortisol, P-glycoprotein, ABC transporters, glucocorticoid replacement therapy, congenital adrenal hyperplasia, Addison's disease, adipose tissue, probenecid, obesity, ACTH suppression, ACTH
- MeSH terms
- Addison Disease, Adipose Tissue, Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Animals, Biological Transport, Active, Brain, Cells, Cultured, Corticosterone, Glucocorticoids, Humans, Hydrocortisone, Male, Mice, Inbred C57BL, Obesity, Organ Specificity, RNA, Messenger, Mice, Knockout, ATP-Binding Cassette, Sub-Family C Proteins, Mice, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.